Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2016 published by Global Data now available at Zursh

San Juan: This clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Obstructive Pulmonary Disease (COPD) clinical trials scenario.

This report provides top line data relating to the clinical trials on Chronic Obstructive Pulmonary Disease (COPD).

Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database.

Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe.

Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

- The report provides a snapshot of the global clinical trials landscape -
 Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status -
 The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Key Benefits

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level


Table of Contents

Clinical Trials by Region 
Clinical Trials and Average Enrollment by Country 
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 
Top Five Countries Contributing to Clinical Trials in Europe 
Top Countries Contributing to Clinical Trials in North America 
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 
Top Five Countries Contributing to Clinical Trials in Central and South America 
Clinical Trials by G7 Countries: Proportion of Chronic Obstructive Pulmonary Disease (COPD) to Respiratory Clinical Trials 
Clinical Trials by Phase in G7 Countries 
Clinical Trials in G7 Countries by Trial Status 
Clinical Trials by E7 Countries: Proportion of Chronic Obstructive Pulmonary Disease (COPD) to Respiratory Clinical Trials 
Clinical Trials by Phase in E7 Countries 
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Clinical Trials  Prominent Drugs 
Latest Clinical Trials News on Chronic Obstructive Pulmonary Disease (COPD) 
May 24, 2016: Salford Lung Study results show COPD patients treated with Relvar Ellipta achieve superior reduction in exacerbations compared with ‘usual care’ 
May 18, 2016: GSK presents new data from Breo Ellipta SUMMIT study in patients with COPD at ATS Conference  May 18, 2016: GSK presents efficacy data for Anoro Ellipta in COPD patients who remained symptomatic on tiotropium 
May 18, 2016: An Extrafine ICS/LABA Combination Decreases COPD Exacerbations More Than LABA/LAMA: a Comparative Analysis Versus Bronchodilator Monotherapy 
May 16, 2016: Sunovion Announces Health Outcomes Data On Exacerbation-Related Hospitalizations That Support The Use Of Brovana (Arformoterol Tartrate) Inhalation Solution In People With Moderate-To-Severe COPD At The 2016 ATS Conference 
May 10, 2016: Verona Pharma announces positive results from add-on phase II trial with RPL554 
May 04, 2016: Sunovion Presents New Health Outcomes Data Supporting Brovana (arformoterol tartrate) Inhalation Solution in People with Moderate-to-Severe COPD at the 2016 American Thoracic Society (ATS) International Conference 
Apr 27, 2016: Sunovion Pharmaceuticals Announces Positive Results from Two Phase 3 Clinical Studies Evaluating SUN-101/eFlow (glycopyrrolate) in People with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease 
Apr 04, 2016: Invion Announces Successful Meeting With FDA To Progress Development Of INV102
Mar 15, 2016: Verona Pharma reports positive results from RPL554 dose-finding study 
Clinical Trial Profiles 
Snapshots
Appendix

Please find more about Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2016 at reports.zursh.com

Click on below items to see free updates about the topic covered.

Industry Updates

Click on below items to see free resources and reports about the topic covered.

Free Resources

Contact Information

Simon Sliman
Simon Sliman (write to Simon)
Research Manager
Zursh Inc. www.zursh.com | reports.zursh.com
Email: reports(at)zursh(dot)com
Lloyd Chambers
Lloyd Chambers (write to Lloyd)
Research Manager
Zursh Inc. www.zursh.com | reports.zursh.com
Email: reports(at)zursh(dot)com

Free Research Updates

Get Latest Updates Completely Free When New Research in Your Industry is Released

Free Research Updates

Get Latest Updates Completely Free When New Research in Your Industry is Released

*We Don't Spam